Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
Launched by ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER, PHOENIX · Jan 5, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether taking oral antibiotics after a specific type of surgery for pituitary tumors can help improve nasal and sinus symptoms, reduce the chances of developing sinus infections, and promote healing in the nasal passages. The surgery being studied is called endoscopic transsphenoidal surgery, which is a minimally invasive procedure used to remove pituitary adenomas (tumors in the pituitary gland).
To participate in this study, you need to be an adult between 18 and 85 years old, undergoing surgery for certain types of pituitary tumors, and able to understand some specific questionnaires about your nasal health. Unfortunately, some individuals may not qualify, such as those with a history of severe allergic reactions to antibiotics, certain liver or kidney issues, or other health conditions that could complicate study participation. If you join, you can expect to receive antibiotics after your surgery and be monitored for any changes in your nasal and sinus symptoms. This research aims to improve recovery and outcomes for patients like you after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patient undergoing endoscopic surgery for resection of pituitary tumors for nonfunctioning adenoma, acromegaly, or prolactinoma
- • Adults \>18 and \<85 years of age
- • English speaking and able to understand the ASK Nasal-12 and SNOT-22 scales
- • Free of any physical, mental, or medical condition which, in the opinion of the investigator, makes study participation inadvisable
- Exclusion Criteria:
- • Anaphylaxis/intolerance to the study drugs
- • Cirrhosis, hepatitis
- • Any solid organ transplant or bone marrow transplant. And any patient felt to be immunocompromised by the investigators
- • Renal failure on dialysis
- • Any subject who is unwilling or unable to sign informed consent for the study
- • Pregnancy
- • Incarcerated patients
- • Cushing's disease
- • Rathke's Cleft cyst or pituitary cyst
- • History of chronic sinusitis
- • Anticipated use of nasal splints
- • Anticipated use of nasal septal flap
- • Active sinusitis
- • Nasal polyps
- • Previous sinus surgery
- • Concurrent antibiotics for another indication (i.e., urinary tract infection)
- • Immunodeficiency
About St. Joseph's Hospital And Medical Center, Phoenix
St. Joseph's Hospital and Medical Center, located in Phoenix, Arizona, is a leading healthcare institution dedicated to providing high-quality patient care and advancing medical research. As a prominent clinical trial sponsor, the hospital is committed to exploring innovative treatments and therapies that enhance patient outcomes. With a focus on ethical research practices and collaboration with multidisciplinary teams, St. Joseph’s is at the forefront of clinical trials that address a wide range of medical conditions, ensuring rigorous scientific standards while prioritizing patient safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Phoenix, Arizona, United States
Patients applied
Trial Officials
Andrew Little, MD
Study Chair
Barrow Brain and Spine
James Evans, MD
Study Chair
Thomas Jefferson University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials